Answer
Apr 27, 2026 - 12:29 PM
Veozah (fezolinetant) has been shown in clinical trials to significantly reduce the frequency and severity of moderate to severe hot flashes in menopausal women compared to placebo. Many women experience noticeable improvement within weeks of starting treatment. However, individual responses may vary, and some side effects are possible.
